Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Fortum Corporation: Managers' transactions – Simon-Erik Ollus

FORTUM CORPORATION STOCK EXCHANGE RELEASE 17 MAY 2022 AT 11:00 EEST Release category: Managers’ transactions Person subject to the notification requirement Name: Ollus, Simon-Erik Position: Other senior manager Issuer: Fortum Corporation LEI: 635400IUIZZIUJSAMF76 Notification type: INITIAL NOTIFICATION Reference number: 635400IUIZZIUJSAMF76_20220516124109_149 Transaction date: 2022-05-13 Venue: XHEL Instrument type: SHARE ISIN: FI0009007132 Nature of the transaction: ACQUISITION Transaction details (1): Volume: 193 Unit price: 16.8189 EUR

3 additional companies to present at the BioStock Life Science Spring Summit

On June 8-9, it is finally time for BioStock Life Science Spring Summit 2022, where companies from a wide range of therapeutic areas will present their projects and innovations, in a packed program that also offers valuable insights from investment experts and industry profiles. Today, we reveal three new companies that will present at the Spring Summit!The event will be broadcasted on the BioStock website and on our YouTube channel. You can also access the event through our social media platforms. Today, we reveal three new companies that will present at the BioStock Life Science Spring

BioStock: Focus on company split for Respiratorius during Q4

Lund-based Respiratorius is currently undergoing an extensive transformation where the company’s two development projects are being separated. That process set the tone for the company’s report for the fourth quarter of the fiscal year 2021/2022, which this time included four months, instead of the customary three. BioStock contacted Respiratorius’ CEO Johan Drott to find out more about what is going during this transformative time for the company.Read the full article at biostock.se:https://www.biostock.se/en/2022/05/focus-on-company-split-for-respiratorius-during-q4/This is a press

BioStock: Ultimovacs keeps delivering in Q1

Q1 saw Norwegian immuno-oncology company Ultimovacs advance on a number of fronts. The company’s clinical programmes with universal cancer vaccine UV1 and adjuvant platform TET have continued to progress steadily. Moreover, milestones were reached at the preclinical level as well as the intellectual property level.Read the article at biostock.se : https://www.biostock.se/en/2022/05/ultimovacs-keeps-delivering-in-q1/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Vattenfall once again number one in biodiversity ranking

Vattenfall has once again taken first place in Ecogain’s biodiversity index.  Some of the largest companies across Europe have been assessed, with  Ecogain evaluating biodiversity performance in their business operations.Ecogain is a Swedish environmental consulting company, specialized in biodiversity and has been conducting rankings since 2020. In this year’s ranking, Ecogain has expanded their evaluation – from companies in the Nordics and Baltics – to companies all over Europe. And like last year, Vattenfall takes the first place in the ranking for 2022. – At Vattenfall, we have an

Tele2 issues first sustainability linked bond

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) has successfully issued its first sustainability linked bond following the recent publication of its Green and Sustainability-Linked Financing Framework.The sustainability-linked bond is a SEK 1.6 billion five-year dual tranche senior unsecured bond with the final redemption price based on Tele2 achieving sustainability performance targets (“SPTs”) linked to its Green and Sustainability-Linked Financing Framework. The SPTs for Tele2’s sustainability linked financing are: · Reduction of Scope 1 & 2 greenhouse gas

Invitation to presentation of Cantargia’s report for the first quarter of 2022 on May 23 at 10.00 a.m. CET

Cantargia AB will publish the company’s report for the first quarter for 2022 on Monday, May 23, 2022, at 08:30 a.m. CET.In conjunction to the report, Cantargia invites investors, analysts, and media to an audiocast with teleconference (in English) on May 23, at 10:00 a.m. CET, where Göran Forsberg, CEO, and Bengt Jöndell, CFO, will present Cantargia and comment on the quarterly report for the first quarter 2022, followed by a Q&A-session. The conference call can be followed at: https://tv.streamfabriken.com/cantargia-q1-2022 To attend through telephone, please dial-in at one of the

Capital increase in TORM due to exercise of Restricted Share Units as part of TORM’s incentive program

TORM plc (“TORM”) increases its share capital by 232,011 A-shares (corresponding to a nominal value of USD 2,320.11) as a result of the exercise of a corresponding number of Restricted Share Units.   The capital increase is carried out without any pre-emption rights for existing shareholders or others. All 232,011 new shares are subscribed for in cash. 17,724 of the new shares have been subscribed for at DKK 43.4 per A-share, 14,178 of the new shares have been subscribed for at DKK 64.3 per A-share and the remaining 200,109 new shares have been subscribed for at DKK 53.5 per A-share.

Dignitana AB appoints Chief Financial Officer

Dignitana AB  announces Ulf Jönsson has been appointed Chief Financial Officer, effective 1 July 2022. Ulf has over 20 years of finance experience in multiple sectors including healthcare, technology and manufacturing. He is currently Interim Group Operations Controller for Diab International AB and was previously CFO for MalmbergGruppen, an environmental tech company. He spent 10 years with global med tech Gambro AB as Controller and then Director of Finance prior to the Company’s 2013 acquisition by Baxter. “Ulf brings to Dignitana diverse financial

Enersense has won Fingrid's tender for the construction of the Aurora Line 400kV power line

Enersense International PlcPress release 17 May 2022 at 10:15 a.m.A subsidiary of Enersense International Plc, a provider of zero-emission energy solutions, Enersense PN Oy, which operates in the business area of Power, has won a contract in Fingrid's public procurement tendering process for the Aurora Line’s Pyhänselkä-Herva share. Aurora Line is the new electricity transmission link between Finland and northern Sweden. The value of the contract is approximately EUR 16 million. The project for the construction of the 400kV power line won by Enersense is located from the Pyhänselkä

MilDef wins order for technology delivery to the Swedish Defence Materiel Administration

MilDef has won a new contract for tactical IT to the Swedish Armed Forces. The value of the delivery is SEK 17 million, of which approximately SEK 8 million will be delivered in 2022.The Swedish Defence Materiel Administration, FMV, procures, develops and delivers materiel and services to the Swedish Armed Forces. MilDef has collaborated with FMV since 1997 on tactical IT. The new order will provide the Swedish Armed Forces with essential parts of the digital infrastructure and includes MilDef's own design and production of equipment such as switches and rugged computers in form factor 19"/

Significant System Approval for Peikko by German DIBt

Use of DELTABEAM[®] Composite Beams with Hollow-Core Slabs in the Event of Fire Peikko has received German national technical approval  from DIBt for its DELTABEAM[®] Composite Beams to be used with hollow-core slabs in situations of fire. The Deutsches Institut für Bautechnik (DIBt: German Institute for Structural Engineering) is a technical authority and a service provider for the German construction sector. In cooperation with its research partners, Peikko executed

Paulig invests in Willicroft, a plant-based cheese start-up

Paulig’s venture arm PINC, alongside Rockstart and other co-investors, has invested in Dutch plant-based cheese start-up Willicroft in a €2m pre-series A investment round. Willicroft offers a range of plant-based cheeses, made by combining age-old techniques with planet-friendly ingredients such as beans and pulses.  As a sustainability frontrunner, Paulig actively seeks food and beverage innovations that enable the health and wellbeing of people and the planet. As the first certified B Corp (1) cheese alternative in Europe, Willicroft’s products support this ambition. With this funding, the

iLOQ expands to the USA

iLOQ, a provider of digital access management solutions, will continue to fulfill its growth strategy by expanding to the USA.   Founded in Finland in 2003, iLOQ currently has sales offices in nine countries in Europe, the Middle East and Canada, as well as a global partner network. Starting operations in the USA will advance iLOQ's growth strategy and open up a large new market for the company. Joni Lampinen has been appointed General Manager, iLOQ USA, from the beginning of June and he will report to Heikki Hiltunen. His role is to build a local country organization as

NOTICE OF ANNUAL SHAREHOLDERS’ MEETING IN INCOAX NETWORKS AB

The shareholders of InCoax Network AB, Reg. No. 556794-1363, are hereby invited to attend the annual shareholders’ meeting on 16 June 2022.The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Information regarding the coronavirus  As a precautionary measure to reduce the risk of spreading the coronavirus, the board of directors of InCoax Networks AB (“InCoax”) has decided that the Annual General Meeting will be conducted in accordance with a so-called postal voting procedure.

Interim Report January – March 2022

SUMMARY OF THE INTERIM REPORT During the first quarter, sales in regular wound healing products amounted to MSEK till 1.7 (0.7), and increased by 154% compared with the previous year . The Group's net turnover during the quarter amounted to MSEK 1.8 (3.2). The change in the Group's total sales compared with the previous year is attributable to COVID-19 related sales during Q1 2021.   DEVELOPMENT WITHIN THE GROUP, JANUARY - MARCH 2022 · Net turnover within the Company's regular wound healing products amounted to MSEK 1.7 (0.7). · Total net turnover amounted to MSEK 1.8 (3.2)

Basemark’s Rocksolid Core Adds Over-The-Air Update Capability with SyncShield

Basemark expands its Rocksolid Ecosystem with SyncShield. This brings over-the-air update tools and capabilities to the Rocksolid Core OS and platform enabling automotive OEMs to tap into new revenue streams and business models.Basemark , a leading software enterprise specializing in automotive software, today announced that SyncShield  has joined the Rocksolid Ecosystem. SyncShield is a software enterprise offering over-the-air (OTA) tools for cyber-secure control over connected devices. The cooperation enables cloud-side over-the-air

Cereno Scientific to participate in upcoming investor conferences

Cereno Scientific (XSAT: CRNO B) today announced that the company will participate at multiple upcoming investor conferences where CEO Sten R. Sörensen will present progress of clinical and preclinical development programs and future outlook.ABG Sundal Collier Life Science Summit (virtual) Date/time: May 19, 2022, 8.30-9.00 CET Presenter: CEO Sten R. Sörensen Registration to attend: Please contact your ABGSC contact person Redeye Growth Day 2022 (hybrid) Date/time: June 2, 2022, 8.40-9.00 CET Presenter: Presentation by CEO Sten R. Sörensen (virtual), Q&A by CMO Björn

Immunovia, Inc. achieves Clinical Laboratory Licensure from Rhode Island Dept of Health making IMMray™ PanCan-d test available in 46 US states

LUND, SWEDEN – The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), Clinical Laboratory licensure, allowing physicians in Rhode Island to order the IMMray™ PanCan-d test for their patients.   “Receiving licensure in Rhode Island now allows us to offer IMMray™ PanCan-d in 46 states. We expect additional state licensures to follow, as we work to make IMMray™ PanCan-d accessible to patients across the United States who are at risk for pancreatic cancer,” says Jeff Borcherding, Chief Executive Officer of Immunovia,

Epiroc to relocate operations from Japan to China

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, will relocate the production and development of drill rigs for surface construction from Japan to its facility in Nanjing, China. The production facility in Yokohama, Japan, has been sold and will be closed.  Epiroc’s customer center will be relocated in the Yokohama area to keep supporting customers in Japan with product and application know-how as well as to provide overhauls, rebuilds, and upgrades of their existing fleets.In Nanjing, the manufacturing will benefit

InCoax Networks AB Interim Report, January – March 2022

Regular orders from US-based Fiber/LAN operator and continued discussions with a North American Tier-1 operator. Large interest for the new product D2501.Financial performance January – March 2022 · Net sales amounted to SEK 5,688,149 (5,170,689), higher sales than the previous year, driven by sales to a US-based Fiber/LAN operator. · Operating profit amounted to SEK -6,293,170 (–7,110,805), an improvement driven by increased sales and a positive gross profit. · Earnings after tax amounted to SEK -6,325,613 (–7,131,222), and earnings per share amounted to SEK -0.15 (–0.26).

New data from NeoDynamics’ PULSE study presented at major US breast imaging conference

Data from the NeoDynamics’ PULSE study with its biopsy device NeoNavia shows a success rate of 96% in very complex and risky axilla biopsies. The new data was presented by Professor Marc Thill at the SBI/ACR Breast Imaging Symposium in Savannah, Georgia. The conference, taking place on May 16-19, is held to be the most important annual meeting for US breast imaging professionals. That the new data was selected for oral presentation at the US conference indicates a strong interest in the results among breast biopsy specialists. The study illustrates the significant contribution NeoNavia

Transfer of Pihlajalinna Plc’s own shares

Pihlajalinna Plc                            Stock exchange release           17 May 2022 at 9.15 a.m.   Transfer of Pihlajalinna Plc’s own shares   Based on the decision of the General Meeting held on 13 April 2022, Pihlajalinna Plc has complemented the number of own shares transferred on 12 May 2022 and on 16 May 2022 transferred as a complement a total of 962 own shares possessed by the company to the members of the Board of Directors of Pihlajalinna as part of the Board’s remuneration.   After the transfer, the company possesses 70,491 own shares.   Pihlajalinna

SeaMe, the product that prevents ghost fishing, was presented at The Perfect World Foundation event, where Prince Albert of Monaco participated

SeaMe is the invention that can save the lives of millions of animals that get trapped in lost fishing gear. The invention SeaMe allows fishermen to find their equipment that would otherwise remain in the sea and continue to catch fish. SeaMe was presented at The Perfect World Foundation's event in Gothenburg, where Prince Albert of Monaco received an award for his environmental commitment. The new SeaMe invention developed by CMAR AB was presented at the event organized by The Perfect World Foundation. SeaMe has excellent potential and is a solution to prevent ghost fishing. In

There are no items matching the current filter
There are no more items matching the current filter
Back to top